AbCellera vs Caris Life Sciences

AbCellera vs Caris Life Sciences, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AbCellera is on 41/100 and Caris Life Sciences on 59/100.

AbCellera logo
AbCelleraAI-powered platform for antibody discovery and development to create new medicines.
Try AbCellera
Caris Life Sciences logo
Caris Life SciencesCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Try Caris Life Sciences

Where each one leads

AbCellera

Leads on none of the measures we hold for both companies.

Caris Life Sciences

  • our overall score: 59/100 against 41/100
  • agent readiness: 47/100 against 38/100
  • domain rating: 63/100 against 56/100
  • funding raised: $700M against $10.0M

At a glance

MeasureAbCelleraCaris Life Sciences
What it isAI-powered platform for antibody discovery and development to create new medicines.Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
CategoryBiotech, Drug Discovery, Genomics, AI Drug DiscoveryBiotech, MedTech, HealthTech, Genomics
Sells toBusiness modelB2BB2B
OfferingPlatformServices
Founded20122008
HeadquartersVancouver, CanadaIrving, United States
StatusActiveActive

Size, funding and growth

MeasureAbCelleraCaris Life Sciences
EmployeesNot published1,659
Total funding$10.0M$700M
Latest roundPublic OfferingSeries D
ValuationNot published$7.8B
LinkedIn followersNot published77,698

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAbCelleraCaris Life Sciences
StartupHub scoreOur 0-100 rating41/10059/100
Traction35/10060/100
Search visibility4/10022/100
Quality58/10078/100
Agent readinessHow well an AI agent can read and act on the siteF (38/100)D (47/100)
Domain ratingLink authority, 0-10056/10063/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAbCelleraCaris Life Sciences
HostingNot detectedSelf Managed
CDNCloudflareNot detected
CMSWebflowWordPress
AnalyticsGoogle Tag ManagerGoogle Tag Manager

AbCellera vs Caris Life Sciences: common questions

Which is better, AbCellera or Caris Life Sciences?

On our 0-100 score Caris Life Sciences rates higher (59/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do AbCellera and Caris Life Sciences compare on the numbers?

Caris Life Sciences leads on our overall score (59/100 against 41/100), agent readiness (47/100 against 38/100), domain rating (63/100 against 56/100), funding raised ($700M against $10.0M).

Read the full AbCellera review and pricing or the Caris Life Sciences review and pricing. You can also browse other AbCellera alternatives we track.